A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
